Episode 412: Metformin and the MeMeMe Study: Is It Time? episode artwork

EPISODE · Feb 11, 2025 · 27 MIN

Episode 412: Metformin and the MeMeMe Study: Is It Time?

from Heart Doc VIP with Dr. Joel Kahn

Dr. Kahn is hosting an online Reversing Heart Disease Summit. You can register now at: drtalks.com/summit/reversing-heart-disease This week, he takes a deep dive into the potential role of metformin as a drug for cancer prevention, diabetes management, and anti-aging, reporting on several new studies, including the MeMeMe randomized trial. The data is compelling. He also discusses several key topics, including a new study on statins reducing dementia risk, Omega-3's role in slowing aging, the hidden harms of juicing, microplastics in the brain, menopause and artery health, luteolin for dark hair, and the impact of telemedicine coaching on diabetic heart patients.

Episode metadata supplied by the publisher feed · Published Feb 11, 2025

Embed this episode

NOW PLAYING

Episode 412: Metformin and the MeMeMe Study: Is It Time?

0:00 27:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Heart Doc VIP with Dr. Joel Kahn?

This episode is 27 minutes long.

When was this Heart Doc VIP with Dr. Joel Kahn episode published?

This episode was published on February 11, 2025.

Can I download this Heart Doc VIP with Dr. Joel Kahn episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!